These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1825 related articles for article (PubMed ID: 10201372)
41. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064 [TBL] [Abstract][Full Text] [Related]
42. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Shtutman M; Zhurinsky J; Simcha I; Albanese C; D'Amico M; Pestell R; Ben-Ze'ev A Proc Natl Acad Sci U S A; 1999 May; 96(10):5522-7. PubMed ID: 10318916 [TBL] [Abstract][Full Text] [Related]
43. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953 [TBL] [Abstract][Full Text] [Related]
44. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells. Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491 [TBL] [Abstract][Full Text] [Related]
45. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation. Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458 [TBL] [Abstract][Full Text] [Related]
46. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Inomata M; Ochiai A; Akimoto S; Kitano S; Hirohashi S Cancer Res; 1996 May; 56(9):2213-7. PubMed ID: 8616874 [TBL] [Abstract][Full Text] [Related]
47. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines. Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519 [TBL] [Abstract][Full Text] [Related]
48. Expression of cyclins D1 and E in human colon adenocarcinomas. Sutter T; Doi S; Carnevale KA; Arber N; Weinstein IB J Med; 1997; 28(5-6):285-309. PubMed ID: 9604788 [TBL] [Abstract][Full Text] [Related]
50. The Yin-Yang of TCF/beta-catenin signaling. Barker N; Morin PJ; Clevers H Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354 [TBL] [Abstract][Full Text] [Related]
51. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025 [TBL] [Abstract][Full Text] [Related]
52. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Korinek V; Barker N; Morin PJ; van Wichen D; de Weger R; Kinzler KW; Vogelstein B; Clevers H Science; 1997 Mar; 275(5307):1784-7. PubMed ID: 9065401 [TBL] [Abstract][Full Text] [Related]
53. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322 [TBL] [Abstract][Full Text] [Related]
54. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells. Lapham A; Adams JE; Paterson A; Lee M; Brimmell M; Packham G Gene; 2009 Mar; 432(1-2):112-7. PubMed ID: 19124064 [TBL] [Abstract][Full Text] [Related]
55. An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma. McCracken S; Kim CS; Xu Y; Minden M; Miyamoto NG Oncogene; 1997 Dec; 15(24):2929-37. PubMed ID: 9416836 [TBL] [Abstract][Full Text] [Related]
56. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874 [TBL] [Abstract][Full Text] [Related]
57. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. Holnthoner W; Pillinger M; Groger M; Wolff K; Ashton AW; Albanese C; Neumeister P; Pestell RG; Petzelbauer P J Biol Chem; 2002 Nov; 277(48):45847-53. PubMed ID: 12235165 [TBL] [Abstract][Full Text] [Related]
58. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells. Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231 [TBL] [Abstract][Full Text] [Related]
59. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263 [TBL] [Abstract][Full Text] [Related]
60. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]